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Abstract: BACKGROUND: Changes in perfusion are considered to play a key role in the pathophysiol-
ogy of renal disease. Contrast-enhanced ultrasound (CEUS) has shown a promising diagnostic imaging
technique to non-invasively and repetitively quantify tissue perfusion. Examination protocols have varied
between studies regarding US equipment, quantification software, the use of sedation or anaesthesia, and
animals. The purpose of the present study was, to assess the feasibility of a standardized CEUS protocol
for perfusion analysis of both kidneys in nine healthy, non-anaesthetized cats. RESULTS: CEUS was
fairly tolerable for all but one cat. In 6/18 kidneys (2 left, 4 right), a second contrast medium injection
was needed due to motion artifacts. Perfusion variables such as peak intensity (PI), wash-in slope (WIS),
wash-out slope (WOS) and mean transit time (MTT) did not significantly differ between left and right
renal cortex and medulla nor between the cranial and caudal renal cortex within each kidney. In contrast,
for all kidneys, mean PI, WIS, and MTT were significantly higher in the cortex than in the medulla (P
= 0.001, 0.012 and <0.001, respectively). CONCLUSIONS: The herein reported CEUS protocol and the
perfusion measurements may serve as a baseline protocol and normal reference values for the evaluation
of feline patients. However, the protocol and results may be of limited value in uncooperative animals.
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Contrast-enhanced ultrasound of both 
kidneys in healthy, non-anaesthetized cats
Hanna Schweiger1* , Stefanie Ohlerth2 and Bernhard Gerber1
Abstract 
Background: Changes in perfusion are considered to play a key role in the pathophysiology of renal disease. 
Contrast-enhanced ultrasound (CEUS) has shown a promising diagnostic imaging technique to non-invasively and 
repetitively quantify tissue perfusion. Examination protocols have varied between studies regarding US equipment, 
quantification software, the use of sedation or anaesthesia, and animals. The purpose of the present study was, to 
assess the feasibility of a standardized CEUS protocol for perfusion analysis of both kidneys in nine healthy, non-anaes-
thetized cats.
Results: CEUS was fairly tolerable for all but one cat. In 6/18 kidneys (2 left, 4 right), a second contrast medium injec-
tion was needed due to motion artifacts. Perfusion variables such as peak intensity (PI), wash-in slope (WIS), wash-out 
slope (WOS) and mean transit time (MTT) did not significantly differ between left and right renal cortex and medulla 
nor between the cranial and caudal renal cortex within each kidney. In contrast, for all kidneys, mean PI, WIS, and MTT 
were significantly higher in the cortex than in the medulla (P = 0.001, 0.012 and <0.001, respectively).
Conclusions: The herein reported CEUS protocol and the perfusion measurements may serve as a baseline protocol 
and normal reference values for the evaluation of feline patients. However, the protocol and results may be of limited 
value in uncooperative animals.
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Background
In patients with suspected renal disease conventional 
B-mode ultrasound (US) of the kidneys and the entire 
urinary tract is routinely performed [1]. US represents 
a non-invasive imaging technique that has no harmful 
effects on renal function [2]. Nevertheless, ultrasono-
graphic patterns and echogenicity are often non-specific 
for diffuse renal disease [3] and can be largely inconspic-
uous even in the case of marked renal dysfunction [4].
Renal function is closely related to organ blood flow 
and changes in perfusion are considered to play a key 
role in the pathophysiology of renal disease [5]. For this 
reason, additional quantitative information about renal 
perfusion beyond the usual routine diagnostic proce-
dures can be of high diagnostic and prognostic value 
[6]. Most known methods, like computed tomography, 
magnetic resonance imaging or scintigraphy, are less 
appropriate for clinical use due to the need for extensive 
patient manipulation and the inherent cost of equipment 
[7]. Moreover, most contrast media currently in use are 
potentially nephrotoxic and thus contraindicated in cases 
of acute kidney injury [7]. Plasma clearance methods 
enable to estimate global organ blood flow only and the 
renal arterial resistive index derived by pulse-waved Dop-
pler US is considered to be inaccurate [8, 9]. Contrast-
enhanced US (CEUS), a diagnostic imaging technique 
to non-invasively and repetitively quantify tissue perfu-
sion on a capillary level, has been shown promising [10]. 
CEUS makes use of a contrast medium, which consists of 
gas-filled microbubbles, that remain strictly in the vas-
culature [7, 11]. In humans, the administration of a third 
generation microbubble contrast media (SonoVue®) has 
shown few adverse events [12], does not produce hemo-
dynamic instability and can be used within the critically 
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ill population [13]. This particular contrast medium has 
also been used in dogs and cats safely [14].
In human medicine, CEUS has already been accepted 
and recommended for clinical use in a variety of renal 
pathologies [1]. Perfusion patterns in different regions 
of the organ can be assessed [7, 10, 15, 16] and with 
quantitative analysis, changes in renal perfusion may be 
depicted early in the course of renal allograft nephropa-
thy [16–19], renal artery stenosis [20] or experimentally 
induced acute kidney injury [21].
So far, several reports documented the use of CEUS in 
the normal feline kidney [15, 22–24]. However, exami-
nation protocols varied between studies regarding US 
equipment, quantification software, and animals. Most 
studies included the left kidney only [22–24], and cats 
were either anaesthetized [15, 22, 23], sedated [15] or 
unsedated [24]. Anaesthetics significantly influence 
organ perfusion variables determined with CEUS [10, 25, 
26], which has specifically be shown for the feline kidney 
[24]. Moreover, anaesthesia is not suitable for repeated 
data collection in critically ill patients. Buprenorphine is 
a semi-synthetic opioid commonly administered alone to 
cats, which is primarily used as analgesic and can have an 
anxiolytic effect [27]. Furthermore, it can be safely used 
in patients suffering from renal dysfunction [28, 29]. The 
purpose of the present study was, to assess the feasibility 
of a standardized CEUS protocol for perfusion analysis of 
both kidneys in healthy, non-anaesthetized cats adminis-
tered buprenorphine and an infusion with normal saline.
Methods
Animals
Nine cats (8 European Shorthair, 1 British Shorthair) 
with a median age of 10  months (range, 9  months to 
6 years) and a median body weight of 5.4 kg (range, 4.0–
6.8  kg) were included. All animals were deemed to be 
healthy based on physical examination, complete blood 
count, serum biochemical panel including free T4, uri-
nalysis and aerobic bacterial culture, echocardiography 
and abdominal ultrasonography. Cystocentesis for uri-
nalysis was carried out following CEUS to exclude iatro-
genic ultrasonographic changes and neuronal dependent 
distortion of the renal blood flow due to irritation of the 
bladder wall. The study was authorised by the veterinary 
office of the Canton of Zurich (permit number 26/2014).
Contrast‑enhanced US protocol
Prior to US, animals were fasted for at least 12 h and a 
22-gauge indwelling catheter.1 was placed in the cephalic 
vein. Simulating a clinical situation with regard to 
1 VasoVet 22 g, 1 in, 0.9 × 25 mm iv catheter, B. Braun Vet Care, Tuttlingen, 
DE.
patients with upper or lower urinary tract obstruction, 
0.9  % saline.2 was infused intravenously with a rate of 
3 ml/kg/h for 2–3 h and stopped shortly before the injec-
tion of the contrast medium. In addition, buprenor-
phine.3 at a dose of 20  μg/kg was administered 
intravenously 1.25–2 h prior to CEUS. After clipping and 
the application of alcohol and coupling gel, a survey 
B-mode US of the abdomen was performed. The heart 
rate and blood pressure were measured.4 at the distal 
front or hind limb at least three times.
CEUS was performed by a radiologist (SO) using a 
1–5  MHz broadband curvilinear transducer with pulse 
inversion.5 Settings were kept constant for all cats and 
optimized during preliminary trials, based on the expertise 
of the radiologist (oblique ventrodorsal longitudinal plane, 
dual imaging mode, image depth: 5.5  cm, mechanical 
index (MI): 0.06, frame rate: 12  Hz, dynamic range: 40, 
persistence: off, constant time gain compensation and 
focal zone, low pulse repetition frequency, B-mode gain: 
75  %). Cats were in lateral recumbency and manually 
restricted by 1–2 people. While the transducer remained 
in the same position, 0.06  ml/kg of a contrast medium.6 
was injected intravenously as a bolus into a short extension 
line and rapidly flushed with 5 ml of 0.9 % saline. Simulta-
neously, images were acquired for approximately 150 s at a 
rate of one frame per second. CEUS of the left kidney was 
always performed first. Prior to a subsequent injection, 
remaining circulating microbubbles were destroyed with 
the highest MI until there was no subjective evidence of 
contrast in the kidney, liver, spleen and aorta. Minimum 
time lag between two contrast injections was 5  min. A 
maximum of two injections per kidney was performed.
Contrast‑enhanced US analysis
Quantitative analysis was performed by one author (HS) 
using quantification software.7 Automatic and manual 
motion correction was applied. Regions of interest (ROIs) 
were always drawn close to the focal zone, where 
enhancement is most homogeneous [23]. In each cortex, 
2 oval-shaped ROIs of a similar size were drawn in the 
cranial and caudal renal cortex at the same organ depth 
for a later statistical comparison. Their size ranged from 
19.7 to 30.7  mm2 (mean 25.1, SD 2.9), and mean organ 
depth was 29.4  mm (SD 3.0, range 22.6–34.0). In the 
medulla, a smaller ROI ranging in size from 8.2 to 
2 NACL Fresenius sol perf 0.9 % 250 ml Freeflex, Fresenius Kabi, Oberdorf, 
CH.
3 TEMGESIC sol inj 0.3 mg/ml, Reckitt Benckiser, CH.
4 DINAMAP—V100, GE Healthcare, Little Chalfont, UK.
5 iU22, Philips Healthcare, Bothell, Washington, USA.
6 SonoVue®, Bracco, Milano, Italy.
7 QLab, Release 8.1.2; Philips Ultrasound, Bothell, WA, USA.
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13.2 mm2 (mean 10.9, SD 1.7) was drawn at a mean organ 
depth of 22.3  mm (SD 3.4, range 17.1–26.6  mm). The 
medullary ROI was smaller in size to avoid including 
larger vessels. The following perfusion variables (Fig.  1) 
were calculated from the raw data using a commercial 
spreadsheet programme.8 Peak intensity (PI) was defined 
as the highest intensity value minus baseline intensity 
before the initial rise. Wash-in slope (WIS) was calculated 
with the data 10  % above baseline intensity (BI) up to 
85 % of the peak value using a linear regression. Wash-
out slope (WOS) included less data after the peak value 
(85–40  % of peak intensity value) in order to avoid the 
exponentially decaying tail. Mean transit time (MTT) 
was defined as the time from the initial rise until a 50 % 
decrease of peak intensity [30].
Statistical analysis
Statistical analysis was performed using dedicated soft-
ware.9 Association between perfusion variables and sys-
tolic blood pressure, heart rate, creatinine values, age or 
8 Microsoft Excel 2011, Version 14.4.3, Microsoft Corporation, Redmond, 
WA, USA.
9 SPSS, Version 22.0, IBM, Chicago, Illinois, USA.
body weight was evaluated with the Pearson’s correlation 
test. A paired samples t test was used to compare the cal-
culated perfusion variables (PI, WIS, WOS, MTT) within 
each kidney (cranial and caudal cortex, cortex and 
medulla), and between the left and right kidney of each 
cat. Level of significance was P < 0.05.
Results
Feasibility
Side effects from contrast media application were not 
observed in any cat. Systolic blood pressure, heart rate 
and creatinine values were normal and ranged between 
100 and 125  mmHg (mean 115, SD 8.9), 181–218  bpm 
(mean 195, SD 13.7) and 84–129 μmol/l (mean 101, SD 
15.0), respectively. CEUS was fairly tolerated by all but 
one 9 month-old cat. This animal received 4 bolus injec-
tions, however, WOS and MTT could not be determined 
in the right kidney because of motion artifacts. Four of 
the 9 cats (44  %) received a total of 3 injections, while 
the remaining 4 cats (44 %) underwent one CEUS exam 
per kidney (2 injections in total). Of the 6 repeated injec-
tions, 4 were performed in the right kidney. Despite 
repeated injections, little or no enhancement of one 
part of the cortex was seen in 3 kidneys due to artifact. 
Fig. 1 Schematic time intensity curve of a feline kidney. Peak intensity (PI) measured in decibel (dB) was defined as the highest intensity value 
minus baseline intensity (BI) before the initial rise. Wash-in slope (WIS) was calculated with the data 10 % above baseline up to 85 % of the peak 
value using a linear regression. Wash-out slope (WOS) included less data after the peak value (85–40 % of peak intensity value) in order to avoid the 
exponentially decaying tail. Mean transit time (MTT) was defined as the time from the initial rise until a 50 % decrease of peak intensity [30]
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Consequently, just 1 ROI was drawn in the cranial cortex 
of 1 left and the caudal cortex of 2 right kidneys, respec-
tively. Similarly, the renal medulla was only assessable in 
13 of 18 (72 %) kidneys (8 left and 5 right) due to breath-
ing or body movement.
Subjective contrast enhancement
Subjectively, enhancement was first visible at the renal 
hilus and progressed to the interlobar and arcuate arter-
ies, quickly followed by the renal cortex. TICs of the renal 
cortex showed a steep initial slope followed by a short 
plateau after peak intensity and a more gradual decrease 
with an exponentially decaying tail returning almost to BI 
(Fig.  2). Compared to the renal cortex, enhancement of 
the renal medulla occurred later, was less intense with a 
less steep rise, and faded earlier.
Quantitative contrast enhancement
Comparative analysis of left and right kidneys
The mean and SD of the calculated perfusion variables for 
the cortex and medulla of the left and right kidneys are 
shown in Table 1. Perfusion variables did neither correlate 
with systolic blood pressure, heart rate, creatinine values 
nor age or body weight. The mean differences between 
the left and right renal cortex were 3.0 dB for PI (SD 2.0), 
0.2 dB/s for WIs (SD 0.1), 0.01 dB/s for WOs (SD 0.01) and 
10.7 s for MTT (SD 10.8). For the medulla, mean differ-
ences between the left and right kidney were 3.2 dB for PI 
(SD 2.2), 0.15 dB/s for WIs (SD 0.14), 0.02 dB/s for WOs 
(SD 0.03) and 10.6  s for MTT (SD 9.1). Mean perfusion 
values did neither significantly differ between left and 
right renal cortex and medulla nor between the cranial 
and caudal renal cortex within each kidney.
Fig. 2 Analysis of contrast enhancement with QLab Software. B-mode (top right) and CEUS images (top left) of a feline left kidney with a region of 
interest (ROI) in the caudal cortex (yellow dots). The corresponding time–intensity curve (bottom image) shows a steep initial slope followed by a 
plateau and gradually descending slope with an exponentially decaying tail
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Comparative analysis for cortex and medulla
The mean and SD of the calculated perfusion variables 
for the renal cortex and medulla of all kidneys are shown 
in Table 2. PI, WIS, and MTT were significantly higher in 
the cortex compared to the medulla (P = 0.001, 0.012 and 
<0.001, respectively).
Discussion
In the present study, quantitative CEUS perfusion meas-
urements were successfully performed in kidneys of non-
anaesthetized cats with the aim of establishing reference 
values for the used protocol. These results can serve 
as normal reference values for the evaluation of feline 
patients. However, cats with suspected chronic renal dis-
ease are usually older than the investigated study popu-
lation, more data from normal cats is needed including 
various age groups.
Quantitative CEUS perfusion analysis may be affected 
by various factors such as machine settings, organ depth 
or signal processing [10, 15, 31]. Therefore, US machine 
settings should be standardized for every institute, and 
perfusion values may be only valid in line with a particu-
lar protocol. Perfusion values from healthy left feline kid-
neys were recently published using the same US machine 
and perfusion computer software [24], however the type 
of probe was not the same. The present study had an 
overall higher mean body weight that the previous study 
and therefore a lower frequency curvilinear transducer 
had to be used for higher beam penetration.
The subjective renal enhancement pattern observed in 
the present study is consistent with previous research in 
the kidneys of healthy dogs [10] and cats [15, 22]. Micro-
bubbles were first imaged in the renal artery and the 
interlobar arteries followed by a rapid, uniform cortical 
enhancement ending with a slower and less intense med-
ullary enhancement. Subjective results were supported by 
the quantitative analysis where PI, WIS, and MTT were 
significantly lower in the medulla compared to the cortex.
Renal perfusion is generally assumed to be bilaterally 
symmetrical in the absence of renal pathologies or artery 
stenosis [32]. Using a standardized CEUS protocol, mean 
perfusion values measured in the present study were 
indeed not significantly different between related left and 
right kidneys in all cats, but varied between animals, in 
particular PI and MTT. The degree of enhancement may 
vary due to a variable injection time with manual adminis-
tration of contrast medium. It may also reflect an influence 
of age, body weight, heart rate or blood pressure. However, 
in the present study no significant correlations of these var-
iables with perfusion variables were found. WIS and WOS 
varied less between cats. The Wash-in and wash-out slope 
do not vary over time and hence, these perfusion variables 
are least affected by variations in PI [10, 31, 33] and there-
fore applicable for clinical imaging [23]. However, WIS and 
WOS can be influenced by mechanical factors such as the 
saline volume, flushing rate, or the use of a three-way stop-
cock [31]. The bolus of contrast medium was administered 
as a preload over a short extension line and flushed by the 
same volume of saline by one person. Consequently, varia-
tion in cortical WIS in the present study most likely reflects 
the individual physiological changes of the arterial cortical 
blood flow in cats.
In the present study, CEUS was performed in non-
anaesthetized cats, which had received buprenor-
phine at a recommended clinical dose of 20 μg/kg [34]. 
Table 1 Mean ± SD values of renal CEUS perfusion variables of the left and right kidneys in 9 non-anaesthetized, healthy 
cats
No significant differences were found between the left and right kidney (cortex and medulla) for all perfusion variables
n number of kidneys (number of ROIs), PI peak intensity, WIs wash-in slope, WOs wash-out slope, MTT mean transit time
Cortex Medulla
Left kidney n Right kidney n Left kidney n Right kidney n
PI (dB) 14.1 ± 3.0 9 (17) 13.8 ± 3.9 9 (16) 10.0 ± 3.7 8 (8) 12.3 ± 5.6 5 (5)
WIS (dB/s) 1.6 ± 1.3 9 (17) 1.7 ± 1.5 9 (16) 0.5 ± 0.2 8 (8) 0.6 ± 0.2 5 (5)
WOS (dB/s) −0.16 ± 0.04 9 (17) −0.15 ± 0.04 8 (14) −0.15 ± 0.05 8 (8) −0.16 ± 0.06 5 (5)
MTT (s) 97.6 ± 22.6 9 (17) 98.5 ± 21.2 8 (14) 65.7 ± 13.2 8 (8) 70.3 ± 15.4 5 (5)
Table 2 Mean ±SD values of  renal CEUS perfusion vari-
ables in the cortex and medulla of the kidneys in nine non-
anaesthetized, healthy cats
n number of kidneys (number of ROIs), PI peak intensity, WIs wash-in slope, WOs 
wash-out slope, MTT mean transit time
* Mean PI, WIS, and MTT were significantly higher in the cortex than in the 
medulla (P < 0.05)
Cortex n Medulla n
PI (dB)* 14.0 ± 3.4 18 (33) 10.9 ± 4.4 13 (13)
WIS (dB/s)
* 1.7 ± 1.4 18 (33) 0.5 ± 0.2 13 (13)
WOS (dB/s) −0.15 ± 0.04 17 (31) −0.15 ± 0.05 13 (13)
MTT (s)* 98.0 ± 21.6 17 (31) 67.5 ± 13.7 13 (13)
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Buprenorphine is a semi-synthetic partial mu-receptor 
opioid agonist with a delayed onset of analgesic action 
at 30 min and a peak effect at 1.5 h, when administered 
intravenously. In cats maximal plasma concentration 
has been detected at 10–45  min [32]. In the present 
study CEUS of the feline kidneys was conducted when 
the maximal effect of buprenorphine was expected. 
Buprenorphine has moderate long-acting (6  h) analge-
sic properties with few adverse effects [34, 35], minimal 
respiratory depression and no significant haemody-
namic effects [36, 37]. Moreover, buprenorphine can 
have an anxiolytic effect in animals [27]. Most of the 
studied cats became more affectionate and were purr-
ing. Nonetheless, body movement had to be minimized 
by manual restriction. Whereas the animals of the pre-
sent study were young, healthy and agile cats, animals 
suffering from severe renal dysfunction are seriously or 
even critically ill patients [38, 39] and for this reason 
considerably less active. However, that might depend 
on the cats character, thus the CEUS protocol used in 
the present study is not recommend for hyperactive or 
aggressive animals. The premedication with buprenor-
phine may be of value, in particular, because general 
anaesthesia is considered to be a contraindication in 
case of renal disease. Common anaesthetics influence 
renal function, generally reducing glomerular filtration 
rate and urine output [40].
Time and effort needed for performing CEUS was 
minimal in the present study. However, quantification of 
CEUS perfusion represents a time-consuming post-pro-
cessing procedure, and therefore, results are not readily 
available for the clinician.
Motion artifacts caused by the individual were encoun-
tered commonly in the present study and gave rise to a 
second injection in 6/18 kidneys, most frequently in the 
right kidney (4/6). Although the feline kidneys usually 
lie more caudal to the rib cage than in dogs [33], possible 
reasons may be (1) a more cranial position of the right 
kidney and its proximity to the rib cage causing coupling 
artifacts, in particular in male cats [41], and (2) the CEUS 
protocol assessing the right kidney at last and after repo-
sitioning the animal.
Due to motion artifacts, quantitative analysis of the 
medulla was not possible in 5 kidneys. Because of the 
typical architecture of the renal medulla which is pyra-
midically separated by interlobar arteries and surrounded 
by the cortex, size of medullary ROIs is basically smaller 
than in the cortex and their positioning is more difficult 
making them more susceptible to organ motion [15]. 
Variation of perfusion variables caused by ROI size is less 
than by ROI depth and most affected parameter is the PI 
[23].
Conclusions
It was shown that CEUS can be performed successfully 
in non-anaesthetized cats premedicated with buprenor-
phine. Perfusion values were determined for the nor-
mal left and right renal cortex and medulla. The CEUS 
protocol and the perfusion measurements can serve as 
a baseline protocol and normal reference values for the 
evaluation of feline patients. However, they may be of 
limited value in uncooperative animals.
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